fig4

Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience

Figure 4. Kaplan-Meier survival analysis of patients with advanced hepatocellular carcinoma according to cycles of immunotherapy therapy and compared to control group (P = ns)

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/